MBK, Unison Capital offer to buy 25 percent of Osstem Implant
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Dentistry Investment, a special purpose company established by Unison Capital and MBK Partners, will conduct a tender offer for Osstem Implant at 190,000 won ($154) per share until Feb. 24, Osstem Implant said in a regulatory filing.
The offer price represents a 51 percent premium on the last three months volume-weighted average price of 125,948 won. It is 17 percent higher than the closing price on Jan. 20 and 16 percent higher than the 52-week high of 162,800 won.
The number of planned purchases ranges from a minimum of 2,394,782 shares, or 15.4 percent of the total potential shares outstanding, to a maximum of 11,177,003 shares.
On Jan. 21, UCK and MBK Partners also signed a stock purchase and investment agreement with Osstem Implant Chairman Choi Kyu-ok, the largest shareholder of the company, to buy 1,442,421 of 2,943,718 common shares owned by Choi at 190,000 won per share. With the agreement, the private equity firms aim to secure more than 40 percent of Osstem Implant to fend off KCGI.
KCGI purchased a 5.57 percent stake in Osstem Implant at the end of last year and added 1 percent more this year, becoming the third-largest shareholder of the Korean implant giant. KCGI soon announced a shareholder action. In a letter sent to Osstem Implant on Jan. 19, KCGI proposed corporate value enhancement through a governance reform, arguing that Osstem Implant is undervalued due to poor internal control and inefficient management of subsidiaries.
After the planned tender offer, MBK Partners could create synergy between Osstem Implant and Medit, a local 3D oral scanner manufacturer, which is already under the private equity fund.
MBK Partners acquired Medit from Unison Capital Korea for some 2.4 trillion won last year.
Medit commands 24 percent of the dental scanner market at home and abroad and it is growing fast overseas like Osstem Implant. The global dental scanner market is expected to grow more than 28 percent annually from next year to 2027.
Medit has established sales subsidiaries in the U.S., Germany and China, and has 230 distribution outlets in 100 countries.
Osstem Implant, the unrivaled No. 1 dental implant maker in Korea, is growing fast with annual sales of 500 billion won in 2019, 631.6 billion won in 2020 and 824.6 billion won in 2021. It is ranked fourth in the world in terms of sales and first in terms of sales volume.
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- “설마했는데 푸틴 큰일났다”…‘중대결단’ 내린 미국 독일 - 매일경제
- ‘재드래곤’ 이재용이 쐈다…새해 출산 직원 64명에 공기청정기 선물 - 매일경제
- 與 당대표 가상 양자대결서 안철수 우세...안랩 21% 급등 - 매일경제
- 이재명 “우리 집 난방비 잘못 계산된줄···횡재세 도입 검토” - 매일경제
- 윤석열대통령 취임 첫해 37억 썼다...문재인 정부와 비교해보니 - 매일경제
- “우리집 거실은 오성급 향기가”…호텔 PB서비스 찾는 고객들 [생생유통] - 매일경제
- 작년 ‘서연고’ 자퇴생 중 76%가 이과…왜 나갔나 보니 - 매일경제
- 반포서 10억 하락 거래 나왔다...도대체 어느 아파트길래 - 매일경제
- “주식 대박 中시장서 나온다”…초고수 투자 핵심은 ‘리오프닝’ - 매일경제
- “이해 하지만 경솔했다” 추신수 작심 발언 접한 야구 선배 쓴 소리 - MK스포츠